Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mainz Biomed (MYNZ) Intangibles (2021 - 2025)

Mainz Biomed's Intangibles history spans 3 years, with the latest figure at $3.0 million for Q4 2024.

  • For Q4 2024, Intangibles fell 11.11% year-over-year to $3.0 million; the TTM value through Dec 2024 reached $3.0 million, down 11.11%, while the annual FY2024 figure was $3.0 million, 11.11% down from the prior year.
  • Intangibles for Q4 2024 was $3.0 million at Mainz Biomed, down from $3.4 million in the prior quarter.
  • Across five years, Intangibles topped out at $3.4 million in Q4 2023 and bottomed at $1.2 million in Q4 2021.
  • The 3-year median for Intangibles is $3.0 million (2024), against an average of $2.5 million.
  • The largest YoY upside for Intangibles was 11.11% in 2024 against a maximum downside of 11.11% in 2024.
  • A 3-year view of Intangibles shows it stood at $1.2 million in 2021, then surged by 183.62% to $3.4 million in 2023, then dropped by 11.11% to $3.0 million in 2024.
  • Per Business Quant, the three most recent readings for MYNZ's Intangibles are $3.0 million (Q4 2024), $3.4 million (Q4 2023), and $1.2 million (Q4 2021).